Mostrar el registro sencillo del ítem
dc.contributor.author
Pandya, Shivani R.
dc.contributor.author
Singh, Harjeet
dc.contributor.author
Desimone, Martín Federico
dc.contributor.author
Singh, Jagpreet
dc.contributor.author
George, Noble
dc.contributor.author
Jasani, Srushti
dc.date.available
2025-07-03T11:26:45Z
dc.date.issued
2024-01
dc.identifier.citation
Pandya, Shivani R.; Singh, Harjeet; Desimone, Martín Federico; Singh, Jagpreet; George, Noble; et al.; Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions; Royal Society of Chemistry; Materials Advances; 5; 2; 1-2024; 409-431
dc.identifier.uri
http://hdl.handle.net/11336/265114
dc.description.abstract
Cancer is a highly complex disease that affects lives and causes millions of deaths worldwide. Several approaches are currently employed as cancer treatment options. Among them, mitochondrial targeting offers a highly promising approach to precise cancer treatment. Indeed, various engineered nanomaterials loaded with chemotherapeutic drugs were developed to precisely target mitochondria. This review investigates the challenges of cancer treatment, particularly in photodynamic, photothermal, and chemotherapies. Drawing on insights from mitochondrial biology and targeting materials, it unravels the complex connection between cancer, mitochondria, and nanoplatform-based targeted therapy. The attention is specifically on nanoparticles and their emerging role in precisely targeting mitochondria, offering solutions for effective treatment of cancer.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Royal Society of Chemistry
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc/2.5/ar/
dc.subject
Mitochondrial targeting
dc.subject
Targeting materials
dc.subject
Mitochondrial biology
dc.subject.classification
Nano-materiales
dc.subject.classification
Nanotecnología
dc.subject.classification
INGENIERÍAS Y TECNOLOGÍAS
dc.title
Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2025-05-28T12:04:34Z
dc.identifier.eissn
2633-5409
dc.journal.volume
5
dc.journal.number
2
dc.journal.pagination
409-431
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Pandya, Shivani R.. Parul University; India
dc.description.fil
Fil: Singh, Harjeet. Parul University; India
dc.description.fil
Fil: Desimone, Martín Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina
dc.description.fil
Fil: Singh, Jagpreet. Chandigarh University; India
dc.description.fil
Fil: George, Noble. Parul University; India
dc.description.fil
Fil: Jasani, Srushti. Parul University; India
dc.journal.title
Materials Advances
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://pubs.rsc.org/en/content/articlelanding/2024/ma/d3ma00629h
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1039/D3MA00629H
Archivos asociados